CB2 receptor activation reduced fentanyl-induced respiratory depression in mice
The CB2 cannabinoid receptor agonist LY2828360 attenuated fentanyl-induced respiratory depression in normal mice but not in CB2 knockout mice, suggesting a CB2-mediated protective effect.
Quick Facts
What This Study Found
Co-administration of LY2828360 (3 mg/kg) with fentanyl (0.2 mg/kg) attenuated respiratory depression in wild-type mice but not CB2 knockout mice, confirming the effect was CB2-mediated. LY2828360 alone had no effect on respiratory parameters in either genotype.
Key Numbers
Fentanyl doses: 0.1 and 0.2 mg/kg. LY2828360 dose: 3 mg/kg. Higher fentanyl dose produced greater respiratory suppression. CB2 agonist attenuated depression in WT but not CB2KO mice.
How They Did This
Whole-body plethysmography in wild-type and CB2 knockout mice. Measured minute ventilation, respiratory frequency, and tidal volume after fentanyl alone vs. fentanyl + LY2828360 co-administration.
Why This Research Matters
Opioid-induced respiratory depression is the primary cause of overdose deaths. A cannabinoid compound that reduces this risk without itself affecting breathing could be a breakthrough in harm reduction.
The Bigger Picture
With fentanyl responsible for more overdose deaths than any other opioid, finding compounds that specifically counteract its respiratory depression while potentially enhancing pain relief represents a promising harm reduction strategy.
What This Study Doesn't Tell Us
Animal study in mice. Unknown whether CB2 agonists would have the same effect in humans. Single dose combination tested. Long-term effects unknown.
Questions This Raises
- ?Would CB2 agonists maintain opioid pain relief while reducing respiratory depression in humans?
- ?Could this approach be developed into a co-formulation with opioids?
Trust & Context
- Key Stat:
- CB2 agonist attenuated fentanyl respiratory depression in wild-type but not knockout mice
- Evidence Grade:
- Well-designed animal study with knockout confirmation of mechanism, but requires human translation.
- Study Age:
- Published in 2021.
- Original Title:
- Cannabinoid CB2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression.
- Published In:
- Cannabis and cannabinoid research, 6(5), 389-400 (2021)
- Authors:
- Zavala, Carmen A, Thomaz, Ana C(2), Iyer, Vishakh(2), Mackie, Ken, Hohmann, Andrea G
- Database ID:
- RTHC-03633
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can cannabinoids prevent opioid overdose?
In mice, a CB2 cannabinoid receptor agonist reduced fentanyl-induced respiratory depression, the primary cause of overdose death. The compound itself did not affect breathing.
How was the CB2 mechanism confirmed?
The protective effect occurred in normal mice but disappeared in mice genetically lacking CB2 receptors, confirming the effect was specifically mediated through CB2.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBD-oil-quality-guide
- CBT-cannabis-recovery
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cannabis-relapse-cycle-pattern
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- medical-benefits-of-cannabis
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-before-surgery
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- seniors-older-adults-cannabis-risks-medications
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-breastfeeding-THC-breast-milk
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-03633APA
Zavala, Carmen A; Thomaz, Ana C; Iyer, Vishakh; Mackie, Ken; Hohmann, Andrea G. (2021). Cannabinoid CB2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression.. Cannabis and cannabinoid research, 6(5), 389-400. https://doi.org/10.1089/can.2020.0059
MLA
Zavala, Carmen A, et al. "Cannabinoid CB2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression.." Cannabis and cannabinoid research, 2021. https://doi.org/10.1089/can.2020.0059
RethinkTHC
RethinkTHC Research Database. "Cannabinoid CB2 Receptor Activation Attenuates Fentanyl-Indu..." RTHC-03633. Retrieved from https://rethinkthc.com/research/zavala-2021-cannabinoid-cb2-receptor-activation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.